Calvin Yeang

4.5k total citations · 4 hit papers
56 papers, 2.7k citations indexed

About

Calvin Yeang is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Calvin Yeang has authored 56 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Surgery, 16 papers in Cardiology and Cardiovascular Medicine and 14 papers in Molecular Biology. Recurrent topics in Calvin Yeang's work include Lipoproteins and Cardiovascular Health (34 papers), Atherosclerosis and Cardiovascular Diseases (11 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (10 papers). Calvin Yeang is often cited by papers focused on Lipoproteins and Cardiovascular Health (34 papers), Atherosclerosis and Cardiovascular Diseases (11 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (10 papers). Calvin Yeang collaborates with scholars based in United States, Netherlands and Canada. Calvin Yeang's co-authors include Sotirios Tsimikas, Joseph L. Witztum, Chelsea Nora, Philip L.S.M. Gordts, Xiaohong Yang, Marlys L. Koschinsky, Jeffrey Kroon, Philippe Pîbarot, Kwan L. Chan and Romain Capoulade and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Immunity.

In The Last Decade

Calvin Yeang

56 papers receiving 2.7k citations

Hit Papers

Oxidized Phospholipids on Lipoprotein(a) Elicit Arterial ... 2015 2026 2018 2022 2016 2019 2015 2022 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Calvin Yeang United States 26 1.8k 951 597 498 449 56 2.7k
Nicholas J. Viney United States 15 1.6k 0.9× 945 1.0× 308 0.5× 709 1.4× 565 1.3× 22 2.4k
Michael B. Boffa Canada 34 2.2k 1.2× 1.1k 1.2× 544 0.9× 691 1.4× 775 1.7× 100 4.2k
Corey A. Scipione Canada 16 913 0.5× 467 0.5× 632 1.1× 208 0.4× 337 0.8× 30 1.7k
Helina Kassahun United States 15 1.7k 0.9× 524 0.6× 357 0.6× 338 0.7× 245 0.5× 30 2.1k
Claudia Stefanutti Italy 25 1.7k 0.9× 667 0.7× 234 0.4× 689 1.4× 186 0.4× 98 2.2k
Marilyn Borgman United States 12 1.7k 0.9× 508 0.5× 339 0.6× 441 0.9× 264 0.6× 12 2.2k
Ransi Somaratne United States 15 3.0k 1.7× 597 0.6× 478 0.8× 705 1.4× 193 0.4× 25 3.3k
Traci Turner United States 12 1.8k 1.0× 478 0.5× 320 0.5× 487 1.0× 457 1.0× 39 2.4k
Hagai Tavori United States 24 1.2k 0.7× 263 0.3× 430 0.7× 232 0.5× 369 0.8× 47 1.8k
Patrick M. Moriarty United States 18 1.3k 0.7× 394 0.4× 190 0.3× 349 0.7× 152 0.3× 40 1.7k

Countries citing papers authored by Calvin Yeang

Since Specialization
Citations

This map shows the geographic impact of Calvin Yeang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Calvin Yeang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Calvin Yeang more than expected).

Fields of papers citing papers by Calvin Yeang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Calvin Yeang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Calvin Yeang. The network helps show where Calvin Yeang may publish in the future.

Co-authorship network of co-authors of Calvin Yeang

This figure shows the co-authorship network connecting the top 25 collaborators of Calvin Yeang. A scholar is included among the top collaborators of Calvin Yeang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Calvin Yeang. Calvin Yeang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bhatia, Harpreet, Rishi Rikhi, Michael Y. Tsai, et al.. (2025). Association of Lipoprotein(a) and Interleukin-6 With Cardiovascular Risk. Journal of the American College of Cardiology. 86(21). 2000–2013. 2 indexed citations
2.
Bax, Willem A., John W. Eikelboom, Arend Mosterd, et al.. (2025). Interleukin-6 modifies Lipoprotein(a) and oxidized phospholipids associated cardiovascular disease risk in a secondary prevention cohort. Atherosclerosis. 405. 119211–119211. 4 indexed citations
3.
Reyes‐Soffer, Gissette, et al.. (2024). High lipoprotein(a): Actionable strategies for risk assessment and mitigation. SHILAP Revista de lepidopterología. 18. 100651–100651. 21 indexed citations
4.
Hoeksema, Marten A., et al.. (2024). Isolation and Cryopreservation of Highly Viable Human Peripheral Blood Mononuclear Cells From Whole Blood: A Guide for Beginners. Journal of Visualized Experiments. 1 indexed citations
5.
Hutten, Barbara A., Sotirios Tsimikas, Calvin Yeang, et al.. (2023). Lipoprotein(a) levels and carotid intima-media thickness in children: A 20-year follow-up study. Journal of clinical lipidology. 18(2). e290–e294. 3 indexed citations
6.
Bhatia, Harpreet, Rishi Rikhi, Calvin Yeang, et al.. (2023). Lipoprotein(a) and the pooled cohort equations for ASCVD risk prediction: The Multi-Ethnic Study of Atherosclerosis. Atherosclerosis. 381. 117217–117217. 12 indexed citations
7.
Bhatia, Harpreet, et al.. (2023). Lipoprotein(a) Testing Trends in a Large Academic Health System in the United States. Journal of the American Heart Association. 12(18). e031255–e031255. 54 indexed citations
8.
Bhatia, Harpreet, S. Gary, Adam Taleb, et al.. (2022). Trends in testing and prevalence of elevated Lp(a) among patients with aortic valve stenosis. Atherosclerosis. 349. 144–150. 18 indexed citations
9.
Yeang, Calvin, Ewa Karwatowska‐Prokopczuk, Fei Su, et al.. (2022). Effect of Pelacarsen on Lipoprotein(a) Cholesterol and Corrected Low-Density Lipoprotein Cholesterol. Journal of the American College of Cardiology. 79(11). 1035–1046. 123 indexed citations breakdown →
10.
Willeit, Peter, Calvin Yeang, Patrick M. Moriarty, et al.. (2020). Low‐Density Lipoprotein Cholesterol Corrected for Lipoprotein(a) Cholesterol, Risk Thresholds, and Cardiovascular Events. Journal of the American Heart Association. 9(23). e016318–e016318. 38 indexed citations
11.
Tsimikas, Sotirios, Philip L.S.M. Gordts, Chelsea Nora, Calvin Yeang, & Joseph L. Witztum. (2019). Statin therapy increases lipoprotein(a) levels. European Heart Journal. 41(24). 2275–2284. 336 indexed citations breakdown →
12.
Boffa, Michael B., Calvin Yeang, Nicholas J. Viney, et al.. (2019). Potent reduction of plasma lipoprotein (a) with an antisense oligonucleotide in human subjects does not affect ex vivo fibrinolysis. Journal of Lipid Research. 60(12). 2082–2089. 43 indexed citations
13.
Senders, Max L., Xuchu Que, Young Seok Cho, et al.. (2018). PET/MR Imaging of Malondialdehyde-Acetaldehyde Epitopes With a Human Antibody Detects Clinically Relevant Atherothrombosis. Journal of the American College of Cardiology. 71(3). 321–335. 34 indexed citations
14.
Moriarty, Patrick M., Calvin Yeang, Stephen A. Varvel, Joseph P. McConnell, & Sotirios Tsimikas. (2018). REMOVING THE LIPOPROTEIN(A)-CHOLESTEROL FROM THE LDL-C MEASUREMENT RESULTS IN A 38% REDUCTION IN PREVALENCE OF ELEVATED LDL-C AT ANY THRESHOLD: IMPLICATIONS FOR THE PREVALENCE AND DIAGNOSIS OF LDL-MEDIATED RISK. Journal of the American College of Cardiology. 71(11). A1783–A1783. 2 indexed citations
15.
Ma, Gary, Michael J. Wilkinson, Calvin Yeang, et al.. (2018). DEDICATED PROGRAM TO ENHANCE MEASUREMENT OF LIPOPROTEIN(A) AMONG PATIENTS UNDERGOING TRANSCATHETER AORTIC VALVE REPLACEMENT. Journal of the American College of Cardiology. 71(11). A1036–A1036. 1 indexed citations
16.
Valk, Fleur M. van der, Siroon Bekkering, Jeffrey Kroon, et al.. (2016). Oxidized Phospholipids on Lipoprotein(a) Elicit Arterial Wall Inflammation and an Inflammatory Monocyte Response in Humans. Circulation. 134(8). 611–624. 454 indexed citations breakdown →
17.
Yeang, Calvin, Ming‐Yow Hung, Young Sup Byun, et al.. (2016). Effect of therapeutic interventions on oxidized phospholipids on apolipoprotein B100 and lipoprotein(a). Journal of clinical lipidology. 10(3). 594–603. 86 indexed citations
18.
Yeang, Calvin, Joseph L. Witztum, & Sotirios Tsimikas. (2015). ‘LDL-C’ = LDL-C + Lp(a)-C. Current Opinion in Lipidology. 26(3). 169–178. 114 indexed citations
19.
Briley‐Sæbø, Karen, Calvin Yeang, Joseph L. Witztum, & Sotirios Tsimikas. (2014). Imaging of Oxidation-Specific Epitopes with Targeted Nanoparticles to Detect High-Risk Atherosclerotic Lesions: Progress and Future Directions. Journal of Cardiovascular Translational Research. 7(8). 719–736. 14 indexed citations
20.
Yeang, Calvin, Shweta Varshney, Renxiao Wang, et al.. (2008). The domain responsible for sphingomyelin synthase (SMS) activity. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1781(10). 610–617. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026